The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.


Evolution in Management of Pulmonary Arterial Hypertension (PAH)

March 2016

Targeting of the Prostacyclin Pathway in PAH Editorial ReviewWritten by: Theodore Bosworth Steeve Provencher, MD, MPH, FRCPCDirector, Pulmonary Hypertension ProgramProfessor, Université LavalQuebec City, Quebec For the treatment...

PRIORITY PRESS - European Academy of Allergy and Clinical Immunology Congress

Current and Future SLIT Tablet Insights

Barcelona, Spain / June 6-10, 2015

Barcelona - Sublingual immunotherapy (SLIT) is working its way into allergy clinics with two oral tablets approved for use in patients with allergic rhinitis to grass pollen in Canada1. This type of therapy has been available in Europe...

MEDICAL FRONTIERS - 36th Annual Congress of the European Society of Cardiology (ESC)

More Aggressive Strategies for Early Detection of Pulmonary Hypertension Supported by Outcome Trials

Barcelona, Spain / August 30-September 3, 2014

Barcelona - Pulmonary arterial hypertension (PAH) should be treated earlier and more aggressively, according to a new analysis of clinical trials with mortality and morbidity endpoints. By demonstrating that outcomes are better when...


Perspectives on Pulmonary Arterial Hypertension (PAH) - Reviews from published literature

February 2014

The 6-Minute Walk Test: Rethinking Outcome Measures in PAH Editorial ReviewWritten by: Theodore Bosworth Paul Hernandez, MDCM, FRCPCRespirologist, QEII Health Sciences CentreProfessor, Department of MedicineDalhousie UniversityHalifax,...


Recent Trial Data Foster New Definitions of Optimal Management for Pulmonary Arterial Hypertension

Chicago, Illinois / October 26-31, 2013

Chicago - As a reflection of progress in the treatment of pulmonary arterial hypertension (PAH), experts speaking at the 2013 Chest meeting contend that they consider normalization of right ventricle function a viable therapeutic goal in at...

ABSTRACTS in PERSPECTIVE - Based on presentations from the Annual Congress of the European Respiratory Society (ERS)

Pulmonary Hypertension: New Therapies in Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension

Barcelona, Spain / September 7-11, 2013

EDITORIAL OVERVIEW: John Granton, MDDirector, Pulmonary Hypertension ProgramToronto General HospitalUniversity of TorontoToronto, Ontario John Swiston, MDDirector, Pulmonary Hypertension ProgramVancouver General HospitalUniversity of...

PRIORITY PRESS - European Respiratory Society (ERS) Annual Congress 2013

Emerging Bronchodilation Strategies for Improved COPD Control and Progression

Barcelona, Spain / September 7-11, 2013

Barcelona - In the treatment algorithm for chronic obstructive pulmonary disease (COPD), the early combination of bronchodilators is expected to be moved forward in guideline-based treatment. In the GOLD (Global Initiative for Chronic...

PRIORITY PRESS - European Respiratory Society (ERS) Annual Congress 2013

COPD Moves Toward Individualization of Care: Based on Need to Maximize Treatment Options

Barcelona, Spain / September 7-11, 2013

Barcelona - Based on a survey presented as a latebreaking presentation at the 2013 ERS, almost all specialists in chronic obstructive pulmonary disease (COPD) are aware of the GOLD (Global Initiative for Chronic Obstructive Lung Disease)...

MEDICAL FRONTIERS - European Respiratory Society (ERS) Annual Congress 2013

New Treatment Options in Pulmonary Arterial Hypertension Appear to Move Treatment Goals Beyond Symptom Control

Barcelona, Spain / September 7-11, 2013

Barcelona - New data presented at the ERS 2013 from trials published just weeks before the meeting was convened, document a paradigm shift in the treatment of pulmonary hypertension. In pulmonary arterial hypertension, the benefit of a new...

PRIORITY PRESS - International Conference of the American Thoracic Society

Updates in the Treatment of Chronic Thromboembolic Pulmonary and Pulmonary Arterial Hypertension

Philadelphia, Pennsylvania / May 17-22, 2013

Philadelphia - Currently, the gold standard for chronic thromboembolic pulmonary hypertension (CTEPH) is pulmonary endarterectomy (PEA) but when patients are deemed inoperable or when symptoms persist or recur following PEA, new medical...

PAGE 1 OF 7   1 2 3 4 5 6 7